These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6490196)

  • 1. Plasma protein-binding of amantadine in maintenance hemodialysis patients.
    Ing TS; Cheng PJ; Wu MJ; Daugirdas JT; Soung LS
    Int J Artif Organs; 1984 Jul; 7(4):235. PubMed ID: 6490196
    [No Abstract]   [Full Text] [Related]  

  • 2. Removal of amantadine hydrochloride by dialysis in patients with renal insufficiency.
    Ing TS; Mahurkar SD; Dunea G; Hayashi JA; Klawans HL; Markey WS
    Can Med Assoc J; 1976 Sep; 115(6):515. PubMed ID: 953934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amantadine toxicity in a patient with renal insufficiency.
    Armbruster KF; Rahn AC; Ing TS; Halper IS; Oyama JH; Klawans HL
    Nephron; 1974; 13(2):183-6. PubMed ID: 4850491
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of hemodialysis and the effects of certain displacing agents on plasma protein binding of sulfamethoxazole and sulfaphenazole in patients with chronic renal failure.
    Kawamura T; Yagi N; Sugawara H; Yamahata K; Takada M
    Chem Pharm Bull (Tokyo); 1980 Jan; 28(1):268-76. PubMed ID: 7363373
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro binding of amantadine to plasma proteins.
    Liu P; Cheng PJ; Ing TS; Daugirdas JT; Jeevanandhan R; Soung LS; Galinis S
    Clin Neuropharmacol; 1984; 7(2):149-51. PubMed ID: 6733694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chloramphenicol hemodialysis clearance.
    Blouin RA; Erwin WG; Dutro MP; Bustrack JA; Rowse KL
    Ther Drug Monit; 1980; 2(4):351-4. PubMed ID: 7222188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The binding of chloramphenicol to serum proteins in patients with chronic renal insufficiency.
    Grafnetterová J; Vodrázka Z; Jandová D; Schück O; Tomásek R; Lachmanová J
    Clin Nephrol; 1976 Oct; 6(4):448-50. PubMed ID: 975643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of amantadine to red blood cells.
    Daugirdas JT; Ing IL; Cheng PJ; Wu MJ; Klawans HL; Soung LS
    Ther Drug Monit; 1984; 6(4):399-401. PubMed ID: 6515702
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of human recombinant erythropoietin therapy on protein metabolism of patients with terminal renal failure on hemodialysis].
    Scigalla P; Fischer C; Park W; Becker H; Schiller R; Paust H; Brösicke H; Kessel M
    Beitr Infusionsther; 1990; 25():430-8. PubMed ID: 1690065
    [No Abstract]   [Full Text] [Related]  

  • 10. Evolution of serum proteins and amino acids on hemodialysis and after kidney transplantation.
    Pascual J; Marcén R; Martin del Rio R; Rivera ME; Naya MT; Teruel JL; Ortuño J
    Contrib Nephrol; 1990; 83():110-5. PubMed ID: 2100699
    [No Abstract]   [Full Text] [Related]  

  • 11. Response of plasma vasopressin to changes in extracellular volume and/or plasma osmolality in patients on maintenance hemodialysis.
    Fasanella d'Amore T; Wauters JP; Waeber B; Nussberger J; Brunner HR
    Clin Nephrol; 1985 Jun; 23(6):299-302. PubMed ID: 4028528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The changes in NT-proBNP plasma concentrations during dialysis are highly dependent of the dialysis membrane ultrafiltration coefficient.
    Dautin G; Boudjeltia S; Soltani Z; Gambert P; Duvillard L
    Clin Chim Acta; 2007 Feb; 376(1-2):237-9. PubMed ID: 16979612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of indomethacin on plasma renin activity response to ultrafiltration in patients undergoing hemodialysis.
    Juncos LI; Marbury TC; Cade R
    Medicina (B Aires); 1983; 43(1):11-5. PubMed ID: 6348468
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sequential ultrafiltration with hemodialysis in treating chronic kidney failure].
    Kulakov GP; Konovalov GA; Melikian AM; Makarova KM
    Urol Nefrol (Mosk); 1983; (1):34-9. PubMed ID: 6829090
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum fetuin-A and aortic calcification in hemodialysis patients.
    Odamaki M; Shibata T; Takita T; Kumagai H
    Kidney Int; 2005 Dec; 68(6):2915; author reply 2916. PubMed ID: 16316382
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of hemofiltration and hemodialysis on contents of trace elements in hair, nails and plasma of patients with chronic renal failure.
    Marumo F; Tsukamoto Y; Iwanami S; Kishimoto T; Yamagami S
    Proc Clin Dial Transplant Forum; 1979; 9():160-4. PubMed ID: 552038
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma protein binding of zolpidem in liver and renal insufficiency.
    Pacifici GM; Viani A; Rizzo G; Carrai M; Ganansia J; Bianchetti G; Morselli PL
    Int J Clin Pharmacol Ther Toxicol; 1988 Sep; 26(9):439-43. PubMed ID: 3198298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum proteins in chronic kidney failure patients under treatment with programmed dialysis].
    Gagarinova AV; Chernyshov VP
    Vrach Delo; 1980 Oct; (10):87-91. PubMed ID: 7434715
    [No Abstract]   [Full Text] [Related]  

  • 19. Accumulation of low molecular weight proteins in patients treated with repeated hemodialysis.
    Naskalski JW; Krzemień D
    Nephron; 1993; 63(4):484. PubMed ID: 8459895
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma calcium fraction dynamics in uremic patients undergoing hemodialysis.
    Asad SN; Olmer AJ; Letteri JM
    Miner Electrolyte Metab; 1984; 10(5):333-6. PubMed ID: 6493162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.